Auro Impex & Chemicals Ltd

Auro Impex & Chemicals Ltd

₹ 50.2 -5.38%
13 Jun - close price
About

Incorporated in 1994, Auro Impex & Chemicals Ltd manufactures, exports, and supplies Discharge
& Collecting Electrodes, and Electrostatic Precipitator
internal parts and spares.[1]

Key Points

Business Overview:[1][2]
AICL, an ISO 9001:2015 certified company, manufactures collecting and discharge electrodes, along with other ESP internal spare parts for OEMs and service providers. Its services include component sourcing, design, manufacturing, and quality testing based on OEM specifications.

AICL also offers niche ESP electrical control solutions using advanced technology to reduce emissions. Additionally, the company is involved in trading activities.

  • Market Cap 61.2 Cr.
  • Current Price 50.2
  • High / Low 94.4 / 45.6
  • Stock P/E 13.2
  • Book Value 38.7
  • Dividend Yield 0.00 %
  • ROCE 10.6 %
  • ROE 10.4 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Contingent liabilities of Rs.39.4 Cr.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 35.1 to 61.6 days.
  • Working capital days have increased from 80.1 days to 112 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
110 173 145 124 139
104 167 139 120 135
Operating Profit 6 6 6 4 4
OPM % 6% 4% 4% 4% 3%
0 1 1 1 1
Interest 2 2 2 2 2
Depreciation 0 0 0 0 0
Profit before tax 5 5 4 3 3
Tax % 27% 28% 31% 29% 21%
3 3 3 2 2
EPS in Rs 3.59 2.84 2.29 2.00 1.79
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
151 232 318 263
145 220 306 254
Operating Profit 5 12 12 9
OPM % 4% 5% 4% 3%
1 1 1 2
Interest 3 4 4 4
Depreciation 1 0 0 0
Profit before tax 3 8 9 6
Tax % 26% 28% 29% 25%
2 6 6 5
EPS in Rs 29.74 6.46 5.14 3.79
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 20%
TTM: -17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 26%
TTM: -26%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -30%
Return on Equity
10 Years: %
5 Years: %
3 Years: 19%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.77 9 12 12
Reserves 11 8 30 35
40 49 35 63
11 16 14 10
Total Liabilities 62 82 91 120
9 9 10 12
CWIP 1 3 6 6
Investments 0 0 0 1
53 70 75 101
Total Assets 62 82 91 120

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-4 3 1 -22
-3 -3 -4 -4
9 5 1 26
Net Cash Flow 3 5 -2 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 40 24 20 62
Inventory Days 59 48 42 51
Days Payable 15 6 7 8
Cash Conversion Cycle 84 66 56 105
Working Capital Days 88 69 59 112
ROCE % 21% 18% 11%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025
71.55% 71.55% 71.55% 71.57%
0.22% 0.00% 0.00% 0.00%
28.24% 28.45% 28.45% 28.43%
No. of Shareholders 1,3771,2641,1631,155

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents